Acesion Pharma
PrivateLast Round
Series B
Sep 26, 2023
Total Funding Raised
$63.47M
Company Overview
Acesion Pharma is a biotechnology company that develops selective small-molecule inhibitors targeting SK channels to treat atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acesion Pharma Comparables
Compare Acesion Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thryv Therapeutics | 81% | |
| Revadix | 78% | |
| HUYA Bioscience International | 78% | |
Acesion Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 26, 2023 | ||||
| Grant | Mar 12, 2019 | ||||
| Series A | Oct 31, 2016 | ||||
| VC Round | Dec 17, 2014 | ||||
| Seed | Dec 15, 2011 | ||||
Seed | Dec 1, 2010 |
Key People
Founding team and executive leadership
Acesion Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| RM Global Partners | Series B |
| Novo Holdings | VC Round, Series B, Seed, Series A |
| Canaan Partners | Series B |
| SEED Capital | Series A |
| Seed Capital | Seed |
| FC Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Developing novel mechanism for rhythm control of atrial fibrillation.
- Mar 12, 2019
$760K grant received from Innovation Fund Denmark.
Acesion Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acesion Pharma's valuation, stock price, and market status.